Photo by Pharmacy Images on Unsplash
Long Covid Medication Coverage Introduced
Germany’s statutory health insurance funds will soon reimburse patients for four specific medications prescribed to treat Long Covid symptoms. Previously, many patients with persistent complaints after Covid-19 infections had to pay out-of-pocket for these drugs. The change aims to ease treatment access and improve care for those still suffering weeks after initial infection, addressing symptoms such as severe fatigue and cognitive impairments.
This development stems from a decision by the Gemeinsame Bundesausschuss (G-BA), which sets binding rules for statutory health insurers in Germany. The committee approved the reimbursement of these medicines in an “Off-Label-Use,” meaning the drugs are prescribed for Long Covid despite not having formal approval for this indication. The approval follows recommendations made by a specialized expert group at the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) tasked with evaluating off-label options for Long Covid treatment [Source 1][Source 7].
Four Approved Medications and Their Use
The four medications include substances commonly used for other conditions:
- Two are approved for treating severe depression and are used to combat persistent fatigue and concentration difficulties within Long Covid patients.
- The others address additional long-term symptoms related to the complex post-Covid syndrome.
These drugs are now formally part of the Arzneimittel-Richtlinie under Anlage VI, allowing physicians to prescribe them at the cost of statutory health insurance providers. However, the pharmaceutical companies must agree to liability coverage for off-label use, a prerequisite for cost reimbursement under the new rules [Source 3][Source 7].
Implications for Expats and Foreign Residents in Germany
This change is particularly relevant for expats, international students, and foreign workers living in Germany who have statutory health insurance coverage. Individuals experiencing lingering Covid-19 symptoms can now receive these medications on prescription without incurring additional costs. This alleviates the financial burden on patients who previously had to pay for such treatment themselves.
Expats should check that their health insurance contracts comply with Germany’s statutory system to benefit from the new reimbursement options. Those insured privately may need to verify their providers’ policies, as this regulation applies explicitly to statutory health insurance. Healthcare providers can now legally offer more therapeutic options, potentially improving recovery chances while maintaining compliance with German healthcare regulations.
Patients experiencing long-term post-Covid symptoms should consult their doctors about this new development and inquire if these reimbursed medications are suitable for their treatment. Awareness of these options can lead to earlier intervention and better management of persistent post-infection health issues [Source 4][Source 5].
For more detailed information, the original German report is available at Tagesschau: Long Covid: Krankenkassen übernehmen bald einzelne Medikamente [Source 1].
